Female Sexual Dysfunction in Androgenetic Alopecia: Case-Control Study

July 2016 in “ Canadian Urological Association journal ”

Eyup Burak Sancak, Sevilay Oguz, Tuğba Özkök Akbulut, Ayşegül Uludağ, Alpaslan Akbas, Omer Kurt, Mehmet Akbulut

androgenetic alopecia female sexual dysfunction metabolic syndrome free testosterone hormones ischemia inflammation AGA FSD MetS

TLDR Hair loss in women linked to higher sexual dysfunction risk.

This case-control study from 2016 investigated the relationship between female sexual dysfunction (FSD) and androgenetic alopecia (AGA) in premenopausal women. The study found that FSD was more prevalent in patients with AGA compared to those without AGA, and that age, AGA, metabolic syndrome, and free testosterone were independent risk factors for FSD. The study suggests that further investigation is needed to understand the role of hormones, ischemia, inflammation, and psychosocial situation on the development of FSD in patients with MetS and/or AGA. The study provides important insights into the relationship between FSD and AGA in premenopausal women.

View this study on cuaj.ca →

Discuss this study in the Community →

Research cited in this study

9 / 9 results

research Female Pattern Alopecia: Current Perspectives

42 citations, August 2013 in “International Journal of Women's Health”

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

research New Investigational Drugs for Androgenetic Alopecia

48 citations, April 2013 in “Expert Opinion on Investigational Drugs”

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

research Improvement in Scalp Hair Growth in Androgen-Deficient Women Treated with Testosterone: A Questionnaire Study

21 citations, October 2011 in “British Journal of Dermatology”

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

research The Association of Insulin Resistance and Metabolic Syndrome in Early Androgenetic Alopecia

18 citations, December 2010 in “PubMed”

People with early hair loss may have higher insulin levels and a greater chance of developing metabolic syndrome.

research Association of Androgenetic Alopecia with Metabolic Syndrome in Men: A Community-Based Survey

69 citations, April 2010 in “British Journal of Dermatology”

Balding men, especially young ones, may have higher risk of heart issues and diabetes; check cholesterol levels.

research Testosterone Therapy for Sexual Dysfunction in Postmenopausal Women

46 citations, January 2008 in “Climacteric”

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

research Hair Loss, Insulin Resistance, and Heredity in Middle-Aged Women: A Population-Based Study

49 citations, June 2003 in “European journal of cardiovascular prevention & rehabilitation”

Hair loss in middle-aged women is often linked to insulin resistance and a family history of hair loss, particularly from their fathers.

research Androgen Replacement in Women: A Commentary

99 citations, June 1999 in “The Journal of Clinical Endocrinology and Metabolism”

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

research Classification of the Types of Androgenetic Alopecia (Common Baldness) Occurring in the Female Sex

666 citations, September 1977 in “British Journal of Dermatology”

Common baldness, also known as Androgenetic Alopecia, is caused by a combination of genetic factors and hormones called androgens.

Similar Research

5 / 1000+ results

research Evidence-Based Approach to Cutaneous Hyperandrogenism in Women

42 citations, July 2015 in “Journal of The American Academy of Dermatology”

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

research Assessment of Female Sexual Dysfunction in Patients with Premenopausal Female Pattern Hair Loss

January 2020 in “Advances in Sexual Medicine”

Female pattern hair loss does not significantly affect sexual dysfunction.

Sexual Function in Women with Androgen Excess Disorders: Classic Forms of Congenital Adrenal Hyperplasia and Polycystic Ovary Syndrome

research Sexual Function in Women with Androgen Excess Disorders: Classic Forms of Congenital Adrenal Hyperplasia and Polycystic Ovary Syndrome

5 citations, June 2020 in “Journal of Endocrinological Investigation”

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

research Clinical Biochemistry of Dihydrotestosterone

50 citations, February 2013 in “Annals of Clinical Biochemistry”

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

research Androgens and Female Sexual Function and Dysfunction—Findings From the Fourth International Consultation of Sexual Medicine

75 citations, February 2016 in “The Journal of Sexual Medicine”

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.